CEDRA Corporation Announces New Company Name

September 21, 2010

Company News Release

CEDRA Corporation

, a division of

Worldwide Clinical Trials

,announces its new company name, Worldwide Clinical Trials Drug Development Solutions. This unified name adds to the continuity and full-service offerings our companies collectively provide.

Worldwide Clinical Trials Drug Development Solutions continues to offer Bioanalytical Sciences and Clinical Research Services, as well as specialized studies to determine the effects of dose, formulation, dosing regimen, drug interactions, genotype, gender and other factors on pharmacokinetics.

Worldwide Clinical Trials and Worldwide Clinical Trials Drug Development Solutions will use their combined medical and scientific expertise to provide service in drug development. Worldwide Clinical Trials specializes in mid-/late-phase, and Worldwide Clinical Trials Drug Development Solutions specializes in bioanalytical/early-phase clinical trials, covering all phases in the clinical trials process.

Related Content:

News